“CO16 | The Predictive Value of High-Sensitivity C-Reactive Protein for Assessing Thrombosis Risk in Non-Small Cell Lung Cancer: P. Gomez-Rosas1,2, M. Marchetti1,3, L. Russo1, C.J. Tartari1, S. Bolognini1, C. Ticozzi1, F. Schieppati1, A. D’Alessio4, R. Labianca5, A. Falanga1,3 All on Behalf of the Hypercan Investigators | 1Hospital Papa Giovanni XXIII, Bergamo, Italy; 2Cardiovascular Research Institute Maastricht, CARIM, Maastricht University, Maastricht, the Netherlands; 3School of Medicine and Surgery, University of Milan Bicocca, Italy; 4University Vita-Salute San Raffaele, Milan, Italy; 5Fondazione ARTET Onlus, Bergamo, Italy”. Bleeding, Thrombosis and Vascular Biology 4, no. s1 (October 22, 2025). Accessed April 28, 2026. https://www.btvb.org/btvb/article/view/220.